Study: Over Half of Binge Eating Disorder Patients Have Used GLP-1 Weight-Loss Drugs
By
Kelsey Mesmer
Summary
A study published in JAMA Psychiatry reveals that over half of patients with binge eating disorder and one-third with atypical anorexia nervosa have used GLP-1 receptor agonists (weight-loss drugs). Researchers warn that the booming weight-loss market has created a "rapidly evolving risk environment" for those with eating disorders, with about 10% of participants obtaining compounded formulations from online providers. Experts urge primary care clinicians to screen for disordered eating before prescribing these medications.
Source
Twitter / XStudy: Over Half of Binge Eating Disorder Patients Have Used GLP-1 Weight-Loss Drugsmdsc.peKey quotes
· 3 pulledMore than half of patients diagnosed with binge eating disorder and one third of patients with atypical anorexia nervosa reported having used GLP-1 receptor agonists
The explosion of the weight-loss market has created a 'rapidly evolving risk environment' for individuals battling eating disorders
Roughly 10% of participants used online providers who prescribed compounded formulations that can be easily obtained
You might also wanna read
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research published in the Journal of Clinical Oncology suggests GLP-1 weight loss medications may reduce cancer risk. An observational s
forbes.com·16d ago
Study: GLP-1 Weight Loss Drugs Linked to Decline in Daily Physical Activity
A new study analyzing NIH All of Us Research Program data, including Fitbit activity records and electronic health records, reveals that adu
neurosciencenews.com·15d ago
Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows
This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p
theverge.com·24d ago
GLP-1 Therapy Reduces Migraine Frequency by More Than Half in Obesity Patients
A study from the University of Naples found that liraglutide, a GLP-1 receptor agonist typically used for diabetes and obesity, significantl
medlink.com·7mo ago
Study Finds GLP-1 Drug Users Show Decreased Physical Activity Levels
A new study presented by doctors at HSHS Saint John's Hospital in Illinois found that people taking GLP-1 drugs like Ozempic and Wegovy sign
gizmodo.com·15d ago
Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs
A study on tirzepatide (a GLP-1 drug) found that after stopping the medication, 82% of participants regained at least 25% of the weight they
arstechnica.com·7mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.